CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.8915
-0.0400 (-4.29%)
At close: Jun 11, 2026, 4:00 PM EDT
0.8909
-0.0006 (-0.07%)
Pre-market: Jun 12, 2026, 4:40 AM EDT
CalciMedica Employees
CalciMedica had 16 employees as of December 31, 2025. The number of employees increased by 2 or 14.29% compared to the previous year.
Employees
16
Change
2
Growth
14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,221,500
Market Cap
14.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 16 | 2 | 14.29% |
| Sep 30, 2025 | 15 | 2 | 15.38% |
| Jun 30, 2025 | 15 | 2 | 15.38% |
| Mar 31, 2025 | 15 | 2 | 15.38% |
| Dec 31, 2024 | 14 | 1 | 7.69% |
| Sep 30, 2024 | 13 | -1 | -7.14% |
| Jun 30, 2024 | 13 | -1 | -7.14% |
| Mar 31, 2024 | 13 | 1 | 8.33% |
| Sep 30, 2023 | 14 | 2 | 16.67% |
| Jun 30, 2023 | 14 | 2 | 16.67% |
| Mar 31, 2023 | 12 | 0 | - |
| Sep 30, 2022 | 12 | 0 | - |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Quince Therapeutics | 38 |
| BioLineRx | 24 |
| Citius Pharmaceuticals | 23 |
| OSR Holdings | 22 |
| Jasper Therapeutics | 22 |
| IN8bio | 17 |
| Cocrystal Pharma | 10 |
CALC News
- 4 weeks ago - CalciMedica Quarterly report: Q1 2026 - Filings
- 4 weeks ago - CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 3 months ago - CalciMedica price target lowered to $10 from $20 at Oppenheimer - TheFly
- 3 months ago - CalciMedica files $125M mixed securities shelf - TheFly
- 3 months ago - CalciMedica Reports 2025 Financial Results and Provides Clinical Updates - PRNewsWire
- 3 months ago - CalciMedica Registration statement: Registration Filing - Filings
- 4 months ago - CalciMedica downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 4 months ago - CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation - PRNewsWire